user_variable,user_description,matched_text,uid,relevance_score,cohere_rank,llm_alignment,llm_rank,cohere_llm_match
submitter_id,A project-specific identifier for a node. This property is the calling card/nickname/alias for a unit of submission. It can be used in place of the UUID for identifying or recalling a node.,UNIQUE COMMUNITY IDENTIFIER,242980,0.33884242,Failure,"ALIGNMENT: To align the new variable with the selected existing variable (UNIQUE SUBJECT ID), you can consider using a similar format for the node identifier as the subject identifier. This could involve assigning a unique identifier to each node in a similar manner as subjects are identified, ensuring that each node has a distinct and identifiable label within the dataset. Additionally, you may want to establish a standardized format or naming convention for the node identifiers to maintain consistency and facilitate data integration and analysis.",Failure,2-Mismatch
submitter_id,A project-specific identifier for a node. This property is the calling card/nickname/alias for a unit of submission. It can be used in place of the UUID for identifying or recalling a node.,UNIQUE SUBJECT ID,242989,0.26683462,Failure,,,
submitter_id,A project-specific identifier for a node. This property is the calling card/nickname/alias for a unit of submission. It can be used in place of the UUID for identifying or recalling a node.,UNIQUE SUBJECT IDENTIFIER,242990,0.26435837,Failure,,,
participant_id,Unique identifier that can be used to retrieve more information for a participant.,PARTICIPANT IDENTIFICATION,177036,0.94407386,Success,"ALIGNMENT: To align the new variable with the selected existing variable ""PARTICIPANT ID,"" ensure that the unique identifier for each participant is structured in a similar format as the existing ""PARTICIPANT ID"" variable. This could involve using a similar numbering system or format for the new variable to maintain consistency with the existing data. Additionally, ensure that the new variable captures the same type of information as the existing ""PARTICIPANT ID"" variable to facilitate harmonization within the dataset.",Success,2-Mismatch
participant_id,Unique identifier that can be used to retrieve more information for a participant.,PARTICIPANT ID,177033,0.9413314,Success,,,
participant_id,Unique identifier that can be used to retrieve more information for a participant.,PARTICIPANT ID NUMBER,177035,0.8513359,Success,,,
consent_codes,"Data Use Restrictions that are used to indicate permissions/restrictions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used.Based on the Data Use Ontology : see http://www.obofoundry.org/ontology/duo.htmlGRU - For general research use for any research purpose. Example of usage: This includes but is not limited to: health/medical/biomedical purposes, fundamental biology research, the study of population origins or ancestry, statistical methods and algorithms development, and social-sciences research.HMB - Use of the data is limited to health/medical/biomedical purposes; does not include the study of population origins or ancestry.DS-X - Use of the data must be related to [disease].NPU - Use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.IRB - Requestor must provide documentation of local IRB/REC approval.",PERMISSION FOR NON-PROFIT USE OF DATA,180823,0.9804313,Neutral,"ALIGNMENT: To align the new variable with ""PERMISSION FOR NON-PROFIT USE OF DATA,"" ensure that the data use restrictions specified fall under non-commercial use by non-profit organizations. This alignment will help maintain consistency in the repository's data permissions and restrictions.",Neutral,Match
consent_codes,"Data Use Restrictions that are used to indicate permissions/restrictions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used.Based on the Data Use Ontology : see http://www.obofoundry.org/ontology/duo.htmlGRU - For general research use for any research purpose. Example of usage: This includes but is not limited to: health/medical/biomedical purposes, fundamental biology research, the study of population origins or ancestry, statistical methods and algorithms development, and social-sciences research.HMB - Use of the data is limited to health/medical/biomedical purposes; does not include the study of population origins or ancestry.DS-X - Use of the data must be related to [disease].NPU - Use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.IRB - Requestor must provide documentation of local IRB/REC approval.",ANY PERMISSION FOR USE - NON-GENETIC DATA,21660,0.9795506,Neutral,,,
consent_codes,"Data Use Restrictions that are used to indicate permissions/restrictions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used.Based on the Data Use Ontology : see http://www.obofoundry.org/ontology/duo.htmlGRU - For general research use for any research purpose. Example of usage: This includes but is not limited to: health/medical/biomedical purposes, fundamental biology research, the study of population origins or ancestry, statistical methods and algorithms development, and social-sciences research.HMB - Use of the data is limited to health/medical/biomedical purposes; does not include the study of population origins or ancestry.DS-X - Use of the data must be related to [disease].NPU - Use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.IRB - Requestor must provide documentation of local IRB/REC approval.",PERMISSION FOR FOR-PROFIT USE OF DATA,180821,0.97923523,Neutral,,,
amputation_type,"If amputated, the amputation type for leg, above the knee or below the knee.  ","13B2. LOWER EXTREMITY AMPUTATION (TOE, FOREFOOT, HEEL, BELOW THE KNEE)",4733,0.8856315,Success,"ALIGNMENT: To align the new variable ""If amputated, the amputation type for leg, above the knee or below the knee"" with the selected existing variable ""LOWER EXTREMITY AMPUTATION (TOE, FOREFOOT, HEEL, BELOW THE KNEE)"", you can map the specific amputation type for leg, above the knee or below the knee to the corresponding categories in the existing variable. This will ensure harmonization and consistency in the data repository.",Success,Match
amputation_type,"If amputated, the amputation type for leg, above the knee or below the knee.  ",AMPUTATION OF LOWER EXTREMITY,19693,0.23231015,Success,,,
amputation_type,"If amputated, the amputation type for leg, above the knee or below the knee.  ",AMPUTATION,19692,0.1183851,Success,,,
cohort_id,"The study subgroup that the participant belongs to. This indicates whether the participant was a postmortem donor, an organ donor, or a surgical donor.  ",DONOR BLOOD GROUP,75719,0.6977119,Failure,"ALIGNMENT: To align the new variable ""The study subgroup that the participant belongs to"" with the existing variable ""DONOR BLOOD GROUP,"" you can categorize the study subgroups (postmortem donor, organ donor, surgical donor) based on the blood group of the participants. This alignment will help in organizing and analyzing the data based on the blood group of the donors in different subgroups.",Failure,Match
cohort_id,"The study subgroup that the participant belongs to. This indicates whether the participant was a postmortem donor, an organ donor, or a surgical donor.  ",DERIVED DUPLICATE DONOR RECIPIENT (BASED ON DONOR'S STUDY ARM AND RECIPIENT),68680,0.45259643,Failure,,,
cohort_id,"The study subgroup that the participant belongs to. This indicates whether the participant was a postmortem donor, an organ donor, or a surgical donor.  ","SUBJECT RECEIVED A STUDY TRANSPLANT (0=NO, 1=YES)",226487,0.3455468,Failure,,,
data_submission_guid,"A Globally Unique IDentifier (GUID) provided by the data submitter, used to identify this subject across multiple projects, commons, etc.",UNIQUE SUBJECT IDENTIFIER,242990,0.9619649,Failure,"ALIGNMENT: To align the new variable ""A Globally Unique IDentifier (GUID)"" with the existing variable ""UNIQUE SUBJECT IDENTIFIER"", ensure that the format and structure of the GUID aligns with the requirements of the UNIQUE SUBJECT IDENTIFIER. This may involve standardizing the format of the GUID to match the existing unique subject identifier format, ensuring that each subject is still uniquely identifiable in the dataset. Additionally, consider any specific guidelines or conventions for assigning GUIDs to subjects to maintain consistency with the existing unique subject identifier.",Failure,Match
data_submission_guid,"A Globally Unique IDentifier (GUID) provided by the data submitter, used to identify this subject across multiple projects, commons, etc.",UNIQUE SUBJECT ID,242989,0.8098782,Failure,,,
data_submission_guid,"A Globally Unique IDentifier (GUID) provided by the data submitter, used to identify this subject across multiple projects, commons, etc.",PUBLIC SUBJECT ID,189115,0.66235983,Failure,,,
derived_parent_subject_id,Unique subject identifier associated with parent project; derived from parent accession and submitted subject ID.,UNIQUE SUBJECT IDENTIFIER,242990,0.97622,Failure,"ALIGNMENT: To align the new variable with the existing variable ""Unique Subject Identifier"", ensure that the new variable captures a unique identifier associated with each subject in the dataset. This identifier should be distinct and not repeated for any subject. Additionally, make sure that the format and structure of the new variable align with the existing unique subject identifier to maintain consistency in the dataset.",Failure,Match
derived_parent_subject_id,Unique subject identifier associated with parent project; derived from parent accession and submitted subject ID.,UNIQUE SUBJECT ID,242989,0.951504,Failure,,,
derived_parent_subject_id,Unique subject identifier associated with parent project; derived from parent accession and submitted subject ID.,SUBJECT ID,226431,0.78282857,Failure,,,
derived_topmed_subject_id,Unique subject identifier associated with TOPMed project; derived from TOPMed accession and submitted subject ID.,UNIQUE SUBJECT IDENTIFIER,242990,0.9887988,Success,"ALIGNMENT: To align the new variable with the existing variable ""UNIQUE SUBJECT IDENTIFIER,"" ensure that the new unique subject identifier associated with the TOPMed project is formatted in a similar way to the existing unique subject identifiers in the repository. This may involve using a standardized format or coding system to maintain consistency across all subject identifiers. Additionally, it is important to ensure that the new unique subject identifier is unique and does not overlap with any existing identifiers in the repository. Regularly updating and cross-referencing the unique subject identifiers will help maintain data integrity and harmonization within the repository.",Success,Match
derived_topmed_subject_id,Unique subject identifier associated with TOPMed project; derived from TOPMed accession and submitted subject ID.,UNIQUE SUBJECT ID,242989,0.97520185,Success,,,
derived_topmed_subject_id,Unique subject identifier associated with TOPMed project; derived from TOPMed accession and submitted subject ID.,DEIDENTIFIED DERIVED PATIENT ID,68150,0.7210563,Success,,,
eligibility,A verification field of whether the Donor has met the overall eligibility criteria for GTEx collection based on answers to eligibility questions. All Eligibility conditions require confirmation from the donor procurement team (staff team where tissue collection and data abstraction takes place) and must be met in order for donor to eligible.  ,ELIGIBILITY VERIFICATION,81775,0.94957596,Success,"ALIGNMENT: To align the new variable with the existing variable ""ELIGIBILITY VERIFICATION,"" ensure that the verification field for meeting overall eligibility criteria for GTEx collection is structured similarly to how eligibility verification is currently recorded in the repository. This may involve using similar criteria, formats, and data structures to maintain consistency and harmonization within the dataset. Additionally, ensure that the confirmation process from the donor procurement team is clearly documented and standardized to facilitate data integration and analysis.",Success,Match
eligibility,A verification field of whether the Donor has met the overall eligibility criteria for GTEx collection based on answers to eligibility questions. All Eligibility conditions require confirmation from the donor procurement team (staff team where tissue collection and data abstraction takes place) and must be met in order for donor to eligible.  ,DONOR MEETS INCL CRITERIA,75867,0.94122344,Success,,,
eligibility,A verification field of whether the Donor has met the overall eligibility criteria for GTEx collection based on answers to eligibility questions. All Eligibility conditions require confirmation from the donor procurement team (staff team where tissue collection and data abstraction takes place) and must be met in order for donor to eligible.  ,GD01: D3. DOES DONOR MEET STANDARD BLOOD CENTER CRITERIA,102932,0.82810634,Success,,,
geographic_site,"""Site where the subject was recruted. ARIC_A=field center A representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_B=field center B representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_C=field center C representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_D=field center D representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), CARDIA_1=field center 1 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_2=field center 2 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_3=field center 3 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_4=field center 4 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CHS_BOWMAN.GRAY=clinic at Bowman Gray University (Forsyth County, NC, USA) for CHS (Cardiovascular Health Study), CHS_DAVIS=clinic at Davis University (Sacramento County, CA, USA) for CHS (Cardiovascular Health Study), CHS_HOPKINS=clinic at Johns Hopkins University (Washington County, MD, USA) for CHS (Cardiovascular Health Study), CHS_PITT=clinic at University of Pittsburgh (Pittsburgh, PA, USA) for CHS (Cardiovascular Health Study), COPDGene_C01=clinical center C01 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C02=clinical center C02 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C03=clinical center C03 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C04=clinical center C04 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C05=clinical center C05 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C06=clinical center C06 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C07=clinical center C07 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C08=clinical center C08 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C09=clinical center C09 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C10=clinical center C10 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C11=clinical center C11 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C12=clinical center C12 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C13=clinical center C13 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C14=clinical center C14 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C15=clinical center C15 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C16=clinical center C16 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C17=clinical center C17 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C18=clinical center C18 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C19=clinical center C19 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C20=clinical center C20 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C21=clinical center C21 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), GENOA_MN=recruitment from Rochester, MN, US, GENOA_MS=recruitment from Jackson, MS, US, GOLDN_MN=recruitment center at Minneapolis, MN, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), GOLDN_UT=recruitment center at Salt Lake City, UT, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), HCHS_SOL_Bronx=recruitment center Bronx, NY, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Chicago=recruitment center Chicago, IL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Miami=recruitment center Miami, FL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_SanDiego=recruitment center San Diego, CA, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), JHS_Hinds=recruitment from urban and rural areas of Hinds county, MS, USA for JHS (Jackson Heart Study), JHS_Madison=recruitment from urban and rural areas of Madison county, MS, USA for JHS (Jackson Heart Study), JHS_Rankin=recruitment from urban and rural areas of Rankin county, MS, USA for JHS (Jackson Heart Study), JHS_Unknown=recruitment from unknown county in MS, USA for JHS (Jackson Heart Study), Mayo_VTE_Midwest_US=state of residence (at time of enrollment for Mayo_VTE study) is in the South region of the USA as defined by the Census Bureau, Mayo_VTE_Northeast_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Northeast region of the USA as defined by the Census Bureau, Mayo_VTE_non_US=state of residence (at time of enrollment for Mayo_VTE study) is from a country outside the USA, Mayo_VTE_South_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Midwest region of the USA as defined by the Census Bureau, Mayo_VTE_West_US=state of residence (at time of enrollment for Mayo_VTE study) is in the West region of the USA as defined by the Census Bureau, MESA_COL=field center/baseline clinic at Columbia University, NY, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_JHU=field center/baseline clinic at Johns Hopkins University, MD, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_NWU=field center/baseline clinic at Northwestern University, IL, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UCLA=field center/baseline clinic at University of California, Los Angeles, CA, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UMN=field center/baseline clinic at University of Minnesota, MN, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_WFU=field center/baseline clinic at Wake Forest University, NC, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), SAS_Apia.urban=recruitment census region of Apia Urban Area in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_NW.Upola=recruitment census region of Northwest Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_rest.Upola=recruitment census region including rest of Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_Savaii=recruitment census region of Savaii in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), WHI_Midwest=recruitment from Midwest region of the USA for WHI (Womens Health Initiative), WHI_Northeast=recruitment from Northeast region of the USA for WHI (Womens Health Initiative), WHI_South=recruitment from South region of the USA for WHI (Womens Health Initiative), WHI_West=recruitment from West region of the USA for WHI (Womens Health Initiative)"" (HARMONIZED)",IS PATIENT ADDRESS IN ARIC COMMUNITY SURVEILLANCE CATCHMENT AREA? Q5B,127229,0.34543642,Neutral,"ALIGNMENT: To align the new variable ""Site where the subject was recruited"" with the existing variable ""ARIC SURVEILLANCE EVENT ID (CIR),"" you can consider creating a mapping or lookup table that links the recruitment site codes (e.g., ARIC_A, ARIC_B, ARIC_C, ARIC_D) to the corresponding ARIC surveillance event IDs. This mapping will allow you to harmonize the new variable with the existing variable by establishing a clear relationship between the recruitment sites and the surveillance events in the ARIC study. Additionally, you may need to ensure consistency in the coding scheme and documentation to facilitate data integration and analysis.",Neutral,2-Mismatch
geographic_site,"""Site where the subject was recruted. ARIC_A=field center A representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_B=field center B representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_C=field center C representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_D=field center D representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), CARDIA_1=field center 1 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_2=field center 2 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_3=field center 3 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_4=field center 4 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CHS_BOWMAN.GRAY=clinic at Bowman Gray University (Forsyth County, NC, USA) for CHS (Cardiovascular Health Study), CHS_DAVIS=clinic at Davis University (Sacramento County, CA, USA) for CHS (Cardiovascular Health Study), CHS_HOPKINS=clinic at Johns Hopkins University (Washington County, MD, USA) for CHS (Cardiovascular Health Study), CHS_PITT=clinic at University of Pittsburgh (Pittsburgh, PA, USA) for CHS (Cardiovascular Health Study), COPDGene_C01=clinical center C01 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C02=clinical center C02 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C03=clinical center C03 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C04=clinical center C04 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C05=clinical center C05 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C06=clinical center C06 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C07=clinical center C07 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C08=clinical center C08 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C09=clinical center C09 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C10=clinical center C10 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C11=clinical center C11 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C12=clinical center C12 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C13=clinical center C13 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C14=clinical center C14 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C15=clinical center C15 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C16=clinical center C16 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C17=clinical center C17 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C18=clinical center C18 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C19=clinical center C19 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C20=clinical center C20 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C21=clinical center C21 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), GENOA_MN=recruitment from Rochester, MN, US, GENOA_MS=recruitment from Jackson, MS, US, GOLDN_MN=recruitment center at Minneapolis, MN, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), GOLDN_UT=recruitment center at Salt Lake City, UT, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), HCHS_SOL_Bronx=recruitment center Bronx, NY, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Chicago=recruitment center Chicago, IL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Miami=recruitment center Miami, FL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_SanDiego=recruitment center San Diego, CA, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), JHS_Hinds=recruitment from urban and rural areas of Hinds county, MS, USA for JHS (Jackson Heart Study), JHS_Madison=recruitment from urban and rural areas of Madison county, MS, USA for JHS (Jackson Heart Study), JHS_Rankin=recruitment from urban and rural areas of Rankin county, MS, USA for JHS (Jackson Heart Study), JHS_Unknown=recruitment from unknown county in MS, USA for JHS (Jackson Heart Study), Mayo_VTE_Midwest_US=state of residence (at time of enrollment for Mayo_VTE study) is in the South region of the USA as defined by the Census Bureau, Mayo_VTE_Northeast_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Northeast region of the USA as defined by the Census Bureau, Mayo_VTE_non_US=state of residence (at time of enrollment for Mayo_VTE study) is from a country outside the USA, Mayo_VTE_South_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Midwest region of the USA as defined by the Census Bureau, Mayo_VTE_West_US=state of residence (at time of enrollment for Mayo_VTE study) is in the West region of the USA as defined by the Census Bureau, MESA_COL=field center/baseline clinic at Columbia University, NY, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_JHU=field center/baseline clinic at Johns Hopkins University, MD, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_NWU=field center/baseline clinic at Northwestern University, IL, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UCLA=field center/baseline clinic at University of California, Los Angeles, CA, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UMN=field center/baseline clinic at University of Minnesota, MN, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_WFU=field center/baseline clinic at Wake Forest University, NC, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), SAS_Apia.urban=recruitment census region of Apia Urban Area in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_NW.Upola=recruitment census region of Northwest Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_rest.Upola=recruitment census region including rest of Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_Savaii=recruitment census region of Savaii in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), WHI_Midwest=recruitment from Midwest region of the USA for WHI (Womens Health Initiative), WHI_Northeast=recruitment from Northeast region of the USA for WHI (Womens Health Initiative), WHI_South=recruitment from South region of the USA for WHI (Womens Health Initiative), WHI_West=recruitment from West region of the USA for WHI (Womens Health Initiative)"" (HARMONIZED)",ARIC SURVEILLANCE EVENT ID (CIR),23167,0.3306873,Neutral,,,
geographic_site,"""Site where the subject was recruted. ARIC_A=field center A representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_B=field center B representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_C=field center C representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_D=field center D representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), CARDIA_1=field center 1 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_2=field center 2 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_3=field center 3 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_4=field center 4 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CHS_BOWMAN.GRAY=clinic at Bowman Gray University (Forsyth County, NC, USA) for CHS (Cardiovascular Health Study), CHS_DAVIS=clinic at Davis University (Sacramento County, CA, USA) for CHS (Cardiovascular Health Study), CHS_HOPKINS=clinic at Johns Hopkins University (Washington County, MD, USA) for CHS (Cardiovascular Health Study), CHS_PITT=clinic at University of Pittsburgh (Pittsburgh, PA, USA) for CHS (Cardiovascular Health Study), COPDGene_C01=clinical center C01 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C02=clinical center C02 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C03=clinical center C03 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C04=clinical center C04 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C05=clinical center C05 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C06=clinical center C06 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C07=clinical center C07 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C08=clinical center C08 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C09=clinical center C09 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C10=clinical center C10 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C11=clinical center C11 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C12=clinical center C12 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C13=clinical center C13 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C14=clinical center C14 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C15=clinical center C15 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C16=clinical center C16 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C17=clinical center C17 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C18=clinical center C18 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C19=clinical center C19 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C20=clinical center C20 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C21=clinical center C21 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), GENOA_MN=recruitment from Rochester, MN, US, GENOA_MS=recruitment from Jackson, MS, US, GOLDN_MN=recruitment center at Minneapolis, MN, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), GOLDN_UT=recruitment center at Salt Lake City, UT, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), HCHS_SOL_Bronx=recruitment center Bronx, NY, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Chicago=recruitment center Chicago, IL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Miami=recruitment center Miami, FL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_SanDiego=recruitment center San Diego, CA, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), JHS_Hinds=recruitment from urban and rural areas of Hinds county, MS, USA for JHS (Jackson Heart Study), JHS_Madison=recruitment from urban and rural areas of Madison county, MS, USA for JHS (Jackson Heart Study), JHS_Rankin=recruitment from urban and rural areas of Rankin county, MS, USA for JHS (Jackson Heart Study), JHS_Unknown=recruitment from unknown county in MS, USA for JHS (Jackson Heart Study), Mayo_VTE_Midwest_US=state of residence (at time of enrollment for Mayo_VTE study) is in the South region of the USA as defined by the Census Bureau, Mayo_VTE_Northeast_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Northeast region of the USA as defined by the Census Bureau, Mayo_VTE_non_US=state of residence (at time of enrollment for Mayo_VTE study) is from a country outside the USA, Mayo_VTE_South_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Midwest region of the USA as defined by the Census Bureau, Mayo_VTE_West_US=state of residence (at time of enrollment for Mayo_VTE study) is in the West region of the USA as defined by the Census Bureau, MESA_COL=field center/baseline clinic at Columbia University, NY, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_JHU=field center/baseline clinic at Johns Hopkins University, MD, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_NWU=field center/baseline clinic at Northwestern University, IL, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UCLA=field center/baseline clinic at University of California, Los Angeles, CA, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UMN=field center/baseline clinic at University of Minnesota, MN, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_WFU=field center/baseline clinic at Wake Forest University, NC, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), SAS_Apia.urban=recruitment census region of Apia Urban Area in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_NW.Upola=recruitment census region of Northwest Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_rest.Upola=recruitment census region including rest of Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_Savaii=recruitment census region of Savaii in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), WHI_Midwest=recruitment from Midwest region of the USA for WHI (Womens Health Initiative), WHI_Northeast=recruitment from Northeast region of the USA for WHI (Womens Health Initiative), WHI_South=recruitment from South region of the USA for WHI (Womens Health Initiative), WHI_West=recruitment from West region of the USA for WHI (Womens Health Initiative)"" (HARMONIZED)",FRAMINGHAM HEART STUDY PARTICIPANT COHORT IDENTIFIER,100179,0.28051782,Failure,,,
index_date,"""Indicates whether the time point reference begins at the donor's actual death, presumed death, or when the cross clamp was applied in the case of surgical donors.""",TIME OF DEATH,234515,0.6204491,Neutral,"ALIGNMENT: To align the new variable with the existing variable ""TIME OF DEATH,"" ensure that the time point reference clearly specifies whether it is referring to the actual time of the donor's death, presumed death, or the application of the cross clamp in surgical donors. This alignment will help maintain consistency and accuracy in recording time-related data in the repository.",Neutral,Match
index_date,"""Indicates whether the time point reference begins at the donor's actual death, presumed death, or when the cross clamp was applied in the case of surgical donors.""",DNR TIME (RELATIVE TO EDARTM),74013,0.46247303,Neutral,,,
index_date,"""Indicates whether the time point reference begins at the donor's actual death, presumed death, or when the cross clamp was applied in the case of surgical donors.""",TIME OF CLINICAL DEATH,234449,0.35655868,Neutral,,,
transplanted_organ,"If the Donor was an Organ Donor, which Organs were donated.",BONE MARROW DONOR,35699,0.44960406,Neutral,"ALIGNMENT: To align the new variable ""If the Donor was an Organ Donor, which Organs were donated"" with the existing variable ""WHAT ORGAN WAS TRANSPLANTED?"", you should ensure that the new variable captures the specific organs that were donated by the organ donor. This alignment will help maintain consistency and clarity in the data repository.",Success,2-Mismatch
transplanted_organ,"If the Donor was an Organ Donor, which Organs were donated.",WHAT ORGAN WAS TRANSPLANTED?,254733,0.26779097,Success,,,
transplanted_organ,"If the Donor was an Organ Donor, which Organs were donated.",BLOOD TYPE OF DONOR,34900,0.14535783,Failure,,,
unit_geographic_site,"harmonization unit for site (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNIT HAS A MATCH [SITE'S OPINION],242996,0.9967523,Failure,"ALIGNMENT: To align the new variable ""harmonization unit for site"" with the selected existing variable ""HARMONIZATION UNIT,"" ensure that the definition and purpose of the new variable match the concept of a defined group of subjects whose phenotypes can be similarly processed. Additionally, consider standardizing the data collection and processing methods for this variable to ensure harmonization with other variables in the dataset.",Failure,Mismatch
unit_geographic_site,"harmonization unit for site (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNIT,242992,0.9775,Neutral,,,
unit_geographic_site,"harmonization unit for site (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.96909106,Neutral,,,
cardiac_output,RV Cardiac output (l/min) (HARMONIZED),RV CARDIAC OUTPUT (ML/MIN),205079,0.9860443,Success,"ALIGNMENT: To align the new variable ""RV Cardiac output (l/min)"" with the selected existing variable ""CARDIAC OUTPUT (L/MIN)"", you should ensure that the measurement units are consistent (both in liters per minute) and specify that it represents the total cardiac output from both ventricles. Additionally, consider including a note or metadata specifying that the data specifically pertains to the right ventricular output within the overall cardiac output measurement. This alignment will help maintain consistency and compatibility within the data repository.",Success,2-Mismatch
cardiac_output,RV Cardiac output (l/min) (HARMONIZED),CARDIAC OUTPUT (L/MIN),42413,0.7856377,Success,,,
cardiac_output,RV Cardiac output (l/min) (HARMONIZED),MEASURED CARDIAC OUTPUT (L/MIN),144968,0.7412996,Success,,,
age_at_bmi_baseline,age at measurement of bmi (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.40574303,Neutral,"ALIGNMENT: To align the new variable ""age at measurement of bmi (years)"" with the existing variable ""AGE AT MEASUREMENT,"" ensure that the age recorded corresponds to the time when the BMI measurement was taken. This will help in harmonizing the new variable with the existing age variable in the data repository.",Neutral,Match
age_at_bmi_baseline,age at measurement of bmi (years) (HARMONIZED),ADULT 1 BMI AT YEAR 1,14898,0.28150436,Neutral,,,
age_at_bmi_baseline,age at measurement of bmi (years) (HARMONIZED),ADULT 4 BMI AT YEAR 1,15157,0.25219983,Neutral,,,
age_at_height_baseline,age at measurement of height_baseline (years) (HARMONIZED),AGE AT BASELINE (YEARS),16530,0.7701192,Success,"ALIGNMENT: To align the new variable ""age at measurement of height_baseline (years)"" with the selected existing variable ""AGE AT BASELINE (YEARS)"", ensure that the measurement of age at the time of height measurement is consistent with the baseline age recorded in the dataset. This may involve cross-referencing the timing of height measurements with the baseline age to ensure accurate alignment. Additionally, consider any adjustments or standardizations that may need to be applied to harmonize the new variable with the existing one.",Success,Match
age_at_height_baseline,age at measurement of height_baseline (years) (HARMONIZED),STANDARDIZED AGE AT BASELINE,222980,0.744842,Success,,,
age_at_height_baseline,age at measurement of height_baseline (years) (HARMONIZED),AGE AT BASELINE,16529,0.68130285,Success,,,
age_at_index,"The subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED). If age is greater than 89 years, see 'age_at_index_gt89'.",SUBJECT AGE,226270,0.41472104,Success,"ALIGNMENT: To align the new variable ""The subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED)"" with the selected existing variable ""SUBJECT AGE,"" ensure that the new variable captures the age of the subject in years accurately and consistently with the existing variable. Make sure to follow the same format and units for age measurement to maintain harmonization within the data repository. Additionally, consider any specific categorizations or age thresholds that may be relevant for your analysis.",Success,Match
age_at_index,"The subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED). If age is greater than 89 years, see 'age_at_index_gt89'.",AGE OF SUBJECT,17285,0.40374315,Success,,,
age_at_index,"The subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED). If age is greater than 89 years, see 'age_at_index_gt89'.","AGE; AGE >89 CATEGORIZED AS "">89""",17616,0.13028543,Success,,,
age_at_index_gt89,Indicate whether the subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED) is greater than 89 years.,"AGE; AGE >89 CATEGORIZED AS "">89""",17616,0.8472108,Neutral,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the criteria for categorizing individuals over the age of 89 as "">89"" is consistent with the definition and coding used in the existing variable. This may involve setting a threshold age value and assigning individuals above that age as "">89"" in the new variable. Additionally, consider any specific instructions or guidelines provided for handling age-related variables in the data repository.",Success,Match
age_at_index_gt89,Indicate whether the subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED) is greater than 89 years.,IS TRUE AGE GREATER THAN 89?,128269,0.55223787,Success,,,
age_at_index_gt89,Indicate whether the subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED) is greater than 89 years.,"AGE (YEARS) 17 = <18, 89 = >88",16399,0.263789,Neutral,,,
age_at_weight_baseline,age at measurement of weight_baseline (years) (HARMONIZED),AGE AT BASELINE (YEARS),16530,0.661595,Success,"ALIGNMENT: To align the new variable ""age at measurement of weight_baseline (years)"" with the selected existing variable ""AGE AT BASELINE (YEARS), ensure that the measurement of age is consistent across all time points and that it specifically refers to the age of the participants at the baseline of the study. This will help maintain consistency and comparability with existing data in the repository.",Success,Match
age_at_weight_baseline,age at measurement of weight_baseline (years) (HARMONIZED),STANDARDIZED AGE AT BASELINE,222980,0.6438893,Success,,,
age_at_weight_baseline,age at measurement of weight_baseline (years) (HARMONIZED),AGE AT BASELINE,16529,0.5809465,Success,,,
annotated_sex,"Subject sex, as recorded by the study. (HARMONIZED)",SEX OF SUBJECT,211860,0.8147908,Success,"ALIGNMENT: To align the new variable ""Subject sex, as recorded by the study (HARMONIZED)"" with the existing variable ""SEX OF SUBJECT,"" ensure that the data collection methods and definitions for recording subject sex are consistent. It is important to clarify whether the variable is capturing biological sex or gender, and ensure that this information is accurately recorded and harmonized with the existing variable. Additionally, consider any specific guidelines or protocols for recording this variable in the data repository to maintain consistency and accuracy.",Success,Match
annotated_sex,"Subject sex, as recorded by the study. (HARMONIZED)",SUBJECTS SEX,226588,0.7243831,Success,,,
annotated_sex,"Subject sex, as recorded by the study. (HARMONIZED)",GENDER (RECORDED AND USED BY BLOCK),103087,0.15190639,Neutral,,,
bmi_baseline,Body mass index calculated at baseline. (kg/m^2) (HARMONIZED),BODY MASS INDEX AT BASELINE,35519,0.9860443,Success,"ALIGNMENT: To align your new variable ""Body mass index calculated at baseline (kg/m^2)"" with the selected existing variable ""BODY MASS INDEX (KG/M^2)"", ensure that the calculation method and units used for the new variable match those of the existing variable. Make sure that the height and weight measurements are accurately recorded and the body mass index is calculated using the formula weight (kg) / height (m^2). This will ensure harmonization with the existing variable in the repository.",Success,3-Mismatch
bmi_baseline,Body mass index calculated at baseline. (kg/m^2) (HARMONIZED),BASELINE BODY MASS INDEX (KG/M SQRD),31003,0.9757161,Success,,,
bmi_baseline,Body mass index calculated at baseline. (kg/m^2) (HARMONIZED),BODY MASS INDEX (KG/M^2),35505,0.89805347,Success,,,
ethnicity,"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino (HARMONIZED). The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.",ETHNICITY - HISPANIC OR LATINO,83708,0.37616467,Success,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the categories and definitions used for self-identification as Hispanic or Latino match those already present in the data repository. Consistency in terminology and definitions will help harmonize the new variable with the existing variable.",Success,Match
ethnicity,"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino (HARMONIZED). The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.",ETHNICITY (HISPANIC OR LATINO),83705,0.34886694,Success,,,
ethnicity,"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino (HARMONIZED). The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.",RACE/ETHNICITY: HISPANIC OR LATINO,193982,0.2979804,Success,,,
height_baseline,Body height at baseline. (cm) (HARMONIZED),BASELINE HEIGHT (CM),31275,0.9514138,Success,"ALIGNMENT: To align the new variable ""Body height at baseline (cm)"" with the selected existing variable ""BASELINE HEIGHT (CM)"", ensure that the measurement units are consistent (cm) and that the timing of the measurement matches the baseline assessment in the dataset. Additionally, consider any specific age group or population criteria that may apply to the existing variable for accurate harmonization.",Success,Match
height_baseline,Body height at baseline. (cm) (HARMONIZED),ADULT 1 HEIGHT (CM) AT BASELINE,14907,0.9449947,Success,,,
height_baseline,Body height at baseline. (cm) (HARMONIZED),ADULT 2 HEIGHT (CM) AT BASELINE,15021,0.9269676,Success,,,
hispanic_subgroup,classification of Hispanic/Latino background for Hispanic/Latino subjects where country or region of origin information is available (HARMONIZED),7-LEVEL RE-CLASSIFICATION OF HISPANIC/LATINO BACKGROUND,10011,0.88059187,Success,"ALIGNMENT: To align the new variable ""classification of Hispanic/Latino background for Hispanic/Latino subjects where country or region of origin information is available (HARMONIZED)"" with the selected existing variable ""7-LEVEL RE-CLASSIFICATION OF HISPANIC/LATINO BACKGROUND,"" you can map the country or region of origin information to the corresponding level in the 7-level classification. This will help in harmonizing the new variable with the existing variable structure and ensure consistency in the data repository.",Success,Match
hispanic_subgroup,classification of Hispanic/Latino background for Hispanic/Latino subjects where country or region of origin information is available (HARMONIZED),CROSS-CLASSIFICATION OF CENTER AND HISPANIC/LATINO BACKGROUND,55433,0.7164171,Success,,,
hispanic_subgroup,classification of Hispanic/Latino background for Hispanic/Latino subjects where country or region of origin information is available (HARMONIZED),"CROSS-CLASSIFICATION OF CENTER AND HISPANIC LATINO BACKGROUND, 45+ YEARS ONLY",55432,0.5832627,Success,,,
population,"CHB Han Chinese in Beijing, China EAS; JPT Japanese in Tokyo, Japan EAS; CHS Southern Han Chinese EAS; CDX Chinese Dai in Xishuangbanna, China EAS; KHV Kinh in Ho Chi Minh City, Vietnam EAS; CEU Utah Residents (CEPH) with Northern and Western European Ancestry EUR; TSI Toscani in Italia EUR; FIN Finnish in Finland EUR; GBR British in England and Scotland EUR; IBS Iberian Population in Spain EUR; YRI Yoruba in Ibadan, Nigeria AFR; LWK Luhya in Webuye, Kenya AFR; GWD Gambian in Western Divisions in the Gambia AFR; MSL Mende in Sierra Leone AFR; ESN Esan in Nigeria AFR; ASW Americans of African Ancestry in SW USA AFR; ACB African Caribbeans in Barbados AFR; MXL Mexican Ancestry from Los Angeles USA AMR; PUR Puerto Ricans from Puerto Rico AMR; CLM Colombians from Medellin, Colombia AMR; PEL Peruvians from Lima, Peru AMR; GIH Gujarati Indian from Houston, Texas SAS; PJL Punjabi from Lahore, Pakistan SAS; BEB Bengali from Bangladesh SAS; STU Sri Lankan Tamil from the UK SAS; ITU Indian Telugu from the UK","RACE/ETHNICITY: ASIAN, NAT AM SET TO OTHER (6)",193981,0.9652504,Neutral,"ALIGNMENT: To align the new variable with the selected existing variable ""RACE/ETHNICITY: ASIAN,"" ensure that the data for CHB Han Chinese in Beijing, Japan, and Southern Han Chinese populations are categorized under the broader category of Asian ethnicity. This will help harmonize the new variable with the existing variable and maintain consistency in the data repository.",Neutral,2-Mismatch
population,"CHB Han Chinese in Beijing, China EAS; JPT Japanese in Tokyo, Japan EAS; CHS Southern Han Chinese EAS; CDX Chinese Dai in Xishuangbanna, China EAS; KHV Kinh in Ho Chi Minh City, Vietnam EAS; CEU Utah Residents (CEPH) with Northern and Western European Ancestry EUR; TSI Toscani in Italia EUR; FIN Finnish in Finland EUR; GBR British in England and Scotland EUR; IBS Iberian Population in Spain EUR; YRI Yoruba in Ibadan, Nigeria AFR; LWK Luhya in Webuye, Kenya AFR; GWD Gambian in Western Divisions in the Gambia AFR; MSL Mende in Sierra Leone AFR; ESN Esan in Nigeria AFR; ASW Americans of African Ancestry in SW USA AFR; ACB African Caribbeans in Barbados AFR; MXL Mexican Ancestry from Los Angeles USA AMR; PUR Puerto Ricans from Puerto Rico AMR; CLM Colombians from Medellin, Colombia AMR; PEL Peruvians from Lima, Peru AMR; GIH Gujarati Indian from Houston, Texas SAS; PJL Punjabi from Lahore, Pakistan SAS; BEB Bengali from Bangladesh SAS; STU Sri Lankan Tamil from the UK SAS; ITU Indian Telugu from the UK",RACE/ETHNICITY: ASIAN,193980,0.9652504,Neutral,,,
population,"CHB Han Chinese in Beijing, China EAS; JPT Japanese in Tokyo, Japan EAS; CHS Southern Han Chinese EAS; CDX Chinese Dai in Xishuangbanna, China EAS; KHV Kinh in Ho Chi Minh City, Vietnam EAS; CEU Utah Residents (CEPH) with Northern and Western European Ancestry EUR; TSI Toscani in Italia EUR; FIN Finnish in Finland EUR; GBR British in England and Scotland EUR; IBS Iberian Population in Spain EUR; YRI Yoruba in Ibadan, Nigeria AFR; LWK Luhya in Webuye, Kenya AFR; GWD Gambian in Western Divisions in the Gambia AFR; MSL Mende in Sierra Leone AFR; ESN Esan in Nigeria AFR; ASW Americans of African Ancestry in SW USA AFR; ACB African Caribbeans in Barbados AFR; MXL Mexican Ancestry from Los Angeles USA AMR; PUR Puerto Ricans from Puerto Rico AMR; CLM Colombians from Medellin, Colombia AMR; PEL Peruvians from Lima, Peru AMR; GIH Gujarati Indian from Houston, Texas SAS; PJL Punjabi from Lahore, Pakistan SAS; BEB Bengali from Bangladesh SAS; STU Sri Lankan Tamil from the UK SAS; ITU Indian Telugu from the UK",PRE-HOSPITAL RACE/ETHNICITY: ASIAN,185451,0.95687664,Neutral,,,
race,"Harmonized race category of participant. Acceptable values: white,american indian or alaska native,black or african american,asian,native hawaiian or other pacific islander,hispanic,multiple,other,Unknown,not reported,not allowed to collect (HARMONIZED)",PARTICIPANT'S RACE (1=HISPANIC 2=ASIAN/PACIFIC ISLANDER 3=AFRICAN AMERICAN 4=CAUCASIAN 5=OTHER),177240,0.82290184,Success,"ALIGNMENT: To align the new variable ""Harmonized race category of participant"" with the selected existing variable ""PARTICIPANT'S RACE"", you can map the acceptable values of the new variable to the corresponding numerical codes in the existing variable. For example, ""white"" can be mapped to 4, ""black or african american"" to 3, ""asian"" to 2, ""hispanic"" to 1, and so on. This alignment will ensure consistency and compatibility with the existing data structure in the repository.",Success,Match
race,"Harmonized race category of participant. Acceptable values: white,american indian or alaska native,black or african american,asian,native hawaiian or other pacific islander,hispanic,multiple,other,Unknown,not reported,not allowed to collect (HARMONIZED)","RACE: AMERICAN INDIAN/ALASKAN NATIVE, ASIAN, OR NATIVE HAWAI'IAN/OTHER PACIFIC ISLANDER",193999,0.4029206,Neutral,,,
race,"Harmonized race category of participant. Acceptable values: white,american indian or alaska native,black or african american,asian,native hawaiian or other pacific islander,hispanic,multiple,other,Unknown,not reported,not allowed to collect (HARMONIZED)","RACE (1 WHITE, 2 BLACK, 3 AMER INDIAN/ALASKAN NATIVE, 4 ASIAN/PACIFIC ISLANDER)",193818,0.38856003,Success,,,
subcohort,"A distinct subgroup within a study, generally indicating subjects who share similar characteristics due to study design. Subjects may belong to only one subcohort. (HARMONIZED)",SUB-COHORT GROUP,226135,0.9468921,Success,"ALIGNMENT: To align the new variable with the selected existing variable ""SUB-COHORT GROUP,"" ensure that the criteria for defining the distinct subgroup within the study are clearly defined and consistent. Consider factors such as demographics, clinical characteristics, or treatment groups to create subcohorts that are meaningful for analysis. Additionally, establish guidelines for assigning subjects to specific subcohorts and document the rationale for subgroup selection to maintain transparency and reproducibility in data harmonization.",Success,Match
subcohort,"A distinct subgroup within a study, generally indicating subjects who share similar characteristics due to study design. Subjects may belong to only one subcohort. (HARMONIZED)",SUBGROUP,226252,0.82544905,Success,,,
subcohort,"A distinct subgroup within a study, generally indicating subjects who share similar characteristics due to study design. Subjects may belong to only one subcohort. (HARMONIZED)",STUDY COHORT,225347,0.761893,Success,,,
unit_annotated_sex,"harmonization unit for annotated_sex (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.9743373,Failure,"ALIGNMENT: To align the new variable ""harmonization unit for annotated_sex"" with the existing variable ""PHENOTYPE,"" you can categorize subjects based on their annotated sex characteristics. This alignment will help in grouping subjects with similar phenotypic traits related to sex, allowing for standardized processing and analysis within the dataset.",Failure,2-Mismatch
unit_annotated_sex,"harmonization unit for annotated_sex (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PHENOTYPE,181522,0.96544635,Failure,,,
unit_annotated_sex,"harmonization unit for annotated_sex (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.9649213,Failure,,,
unit_bmi_baseline,"harmonization unit for bmi_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",BASELINE BODY MASS INDEX,31001,0.9904406,Success,"ALIGNMENT: To align your new variable ""harmonization unit for bmi_baseline"" with the selected existing variable ""BASELINE BODY MASS INDEX,"" ensure that the harmonization unit captures the body mass index measurements of participants at baseline in a consistent and standardized manner. This may involve using the same calculation method and units as the existing variable to maintain compatibility and coherence within the data repository. Additionally, consider incorporating any specific details or nuances related to BMI computation from metric or imperial units if relevant to your harmonization process.",Success,Match
unit_bmi_baseline,"harmonization unit for bmi_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","BMI (COMPUTED BY SC FROM METRIC UNITS) (FROM ANT02,ANT03) AT BASELINE",35268,0.9886244,Success,,,
unit_bmi_baseline,"harmonization unit for bmi_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","BMI (COMPUTED BY SC FROM IMPERIAL UNITS) (FROM IEC05A,B AT BASELINE)",35264,0.98761624,Success,,,
unit_ethnicity,"harmonization unit for ethnicity (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.9829547,Failure,"ALIGNMENT: To align the new variable ""harmonization unit for ethnicity"" with the existing variable ""observation unit,"" you can define specific groups or categories of subjects based on ethnicity within the dataset. This will allow you to analyze and compare data for different ethnic groups within the context of the observation unit, such as individual patients or samples. By harmonizing ethnicity data with the observation unit, you can ensure that the phenotypes of subjects within each defined group are processed and analyzed consistently.",Failure,Match
unit_ethnicity,"harmonization unit for ethnicity (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.9824231,Failure,,,
unit_ethnicity,"harmonization unit for ethnicity (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",2.F HOMOGENEITY,6683,0.98076576,Failure,,,
unit_height_baseline,"harmonization unit for height_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEIGHTUNIT,110384,0.9759464,Success,"ALIGNMENT: To align the new variable ""harmonization unit for height_baseline"" with the existing variable ""HEIGHT"", ensure that the data for height_baseline is recorded in the same unit of measurement as the existing height data. This will allow for easy comparison and analysis of the two variables within the data repository.",Success,Mismatch
unit_height_baseline,"harmonization unit for height_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEIGHT (UNIT),110222,0.9743861,Success,,,
unit_height_baseline,"harmonization unit for height_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNIT OF MEASUREMENT,243002,0.92749476,Success,,,
unit_hispanic_subgroup,"harmonization unit for hispanic_subgroup (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HISPANIC ETHNICITY,112232,0.9947187,Success,"ALIGNMENT: To align the new variable ""harmonization unit for hispanic_subgroup"" with the existing variable ""HISPANIC ETHNICITY"", you should ensure that the harmonization unit captures the ethnicity of individuals as either Hispanic or non-Hispanic. This alignment will help maintain consistency and compatibility with the existing data in the repository.",Success,Match
unit_hispanic_subgroup,"harmonization unit for hispanic_subgroup (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HISPANIC,112230,0.9935369,Success,,,
unit_hispanic_subgroup,"harmonization unit for hispanic_subgroup (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.9658352,Failure,,,
unit_race,"harmonization unit for race (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",RACE (RECODED TO HARMONIZE RESPONSES ACROSS CENTERS),193857,0.9980657,,"ALIGNMENT: To align the new variable ""harmonization unit for race"" with the selected existing variable ""RACE (RECODED TO HARMONIZE RESPONSES ACROSS CENTERS,"" you should ensure that the harmonization unit for race is processed in a consistent manner across different centers to maintain uniformity and comparability of race data. This may involve standardizing the categorization or coding of race responses to ensure harmonization across centers. Additionally, you may need to document the harmonization process to facilitate data interpretation and analysis.",,
unit_race,"harmonization unit for race (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",SUBJECT RACE,226484,0.9955316,,,,
unit_race,"harmonization unit for race (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.98609793,,,,
unit_subcohort,"harmonization unit for subcohort (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",SUB-COHORT GROUP,226135,0.9991639,,"ALIGNMENT: To align the new variable ""harmonization unit for subcohort"" with the existing variable ""SUB-COHORT GROUP,"" you should ensure that the defined groups of subjects for harmonization are clearly identified and organized. This will help in processing and analyzing the phenotypes of these subgroups in a similar manner, leading to more meaningful and accurate results. Additionally, make sure to document the criteria used for defining these harmonization units to maintain transparency and reproducibility in the analysis.",,
unit_subcohort,"harmonization unit for subcohort (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",COHORT,50402,0.99455196,,,,
unit_subcohort,"harmonization unit for subcohort (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.98747206,,,,
unit_weight_baseline,"harmonization unit for weight_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WEIGHT (UNIT),253457,0.97354424,,"ALIGNMENT: To align the new variable ""harmonization unit for weight_baseline"" with the existing variable ""WEIGHT (UNIT)"", ensure that the harmonization unit for weight_baseline is recorded in the same units (e.g., kilograms or pounds) as the weight measurements in the dataset. This will allow for consistency in the representation of weight-related data.",,
unit_weight_baseline,"harmonization unit for weight_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WEIGHT UNITS,253773,0.95799094,,,,
unit_weight_baseline,"harmonization unit for weight_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.9222025,,,,
weight,Body weight at baseline. (kg) (HARMONIZED).,WEIGHT (KG) AT BASELINE,253391,0.96628344,,"ALIGNMENT: To align your new variable ""Body weight at baseline. (kg) (HARMONIZED)"" with the selected existing variable ""WEIGHT AT BASELINE (KG)"", ensure that the units are consistent (kg) and that the measurement is taken at the baseline of the study. Make sure to follow the same data collection methods and definitions as the existing variable to maintain harmonization within the data repository.",,
weight,Body weight at baseline. (kg) (HARMONIZED).,WEIGHT AT BASELINE (KG),253501,0.961678,,,,
weight,Body weight at baseline. (kg) (HARMONIZED).,BASELINE WEIGHT (KG),31737,0.9431385,,,,
weight_baseline,Body weight at baseline. (kg) (HARMONIZED),WEIGHT (KG) AT BASELINE,253391,0.9719925,,"ALIGNMENT: To align the new variable ""Body weight at baseline. (kg)"" with the selected existing variable ""WEIGHT AT BASELINE (KG)"", ensure that the measurement unit is consistent (kg) and that the timing of the measurement is at the baseline of the study. Make sure to capture the weight of the individual accurately at the beginning of the study period.",,
weight_baseline,Body weight at baseline. (kg) (HARMONIZED),WEIGHT AT BASELINE (KG),253501,0.9644556,,,,
weight_baseline,Body weight at baseline. (kg) (HARMONIZED),BASELINE WEIGHT (KG),31737,0.95022655,,,,
age_at_basophil_ncnc_bld,age at measurement of basophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.15291561,,"ALIGNMENT: To align the new variable ""age at measurement of basophil_ncnc_bld (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the measurement of the age of the individual is consistent with the standard practice used for the existing variable. This may involve verifying the method of age calculation, ensuring it is in years, and aligning the timing of measurement with the existing variable. Additionally, consider any specific transformations or adjustments that may be necessary to harmonize the new variable with the selected existing variable.",,
age_at_basophil_ncnc_bld,age at measurement of basophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.07172112,,,,
age_at_basophil_ncnc_bld,age at measurement of basophil_ncnc_bld (years) (HARMONIZED),AGE AT BASELINE (YEARS),16530,0.05350215,,,,
age_at_eosinophil_ncnc_bld,age at measurement of eosinophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.09203286,,"ALIGNMENT: To align the new variable ""age at measurement of eosinophil_ncnc_bld"" with ""TOTAL EOSINOPHIL COUNT, CELLS/MICROLITER,"" ensure that the age at which the eosinophil count was measured is recorded in years. Additionally, specify that the eosinophil count is measured in cells per microliter of blood to maintain consistency with the existing variable. This alignment will help harmonize the new variable with the existing data in the repository.",,
age_at_eosinophil_ncnc_bld,age at measurement of eosinophil_ncnc_bld (years) (HARMONIZED),9E EOSINOPHILS (%),10711,0.027117657,,,,
age_at_eosinophil_ncnc_bld,age at measurement of eosinophil_ncnc_bld (years) (HARMONIZED),"TOTAL EOSINOPHIL COUNT, CELLS/MICROLITER",237142,0.025468083,,,,
age_at_hdl,age at measurement of hdl (years) (HARMONIZED),HDL CHOLESTEROL 6 YEARS,108735,0.7077078,,"ALIGNMENT: To align the new variable ""age at measurement of HDL (years)"" with ""HDL CHOLESTEROL (MG/DL) AT YEAR 1,"" you can use the age information corresponding to the first year of measurement for HDL cholesterol. This will allow for consistent tracking of age and HDL cholesterol levels at the same time point.",,
age_at_hdl,age at measurement of hdl (years) (HARMONIZED),HDL CHOLESTEROL (MG/DL) AT YEAR 1,108717,0.46660253,,,,
age_at_hdl,age at measurement of hdl (years) (HARMONIZED),HDL CHOLESTEROL (MG/DL) AT YEAR 2,108718,0.4434799,,,,
age_at_hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (years) (HARMONIZED)",HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD),110470,0.87976795,,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement of hematocrit is expressed as a percentage of red blood cells in whole blood. This will harmonize the new variable with the existing variable and maintain consistency in the data repository.",,
age_at_hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (years) (HARMONIZED)",BLOOD ANALYSIS: HEMATOCRIT,34250,0.85800624,,,,
age_at_hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (years) (HARMONIZED)",HEMATOCRIT (HCT %),110481,0.8458151,,,,
age_at_hemoglobin_mcnc_bld,age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.16762705,,"ALIGNMENT: To align the new variable ""age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED)"" with the existing variable ""AGE AT MEASUREMENT,"" ensure that the age captured in the new variable corresponds to the age of the individual at the time of hemoglobin measurement. This alignment will help maintain consistency and facilitate comparisons with other data points in the repository.",,
age_at_hemoglobin_mcnc_bld,age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED),DAYS TO DATE OF HGB MEASUREMENT,66283,0.12485182,,,,
age_at_hemoglobin_mcnc_bld,age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.07751766,,,,
age_at_ldl,age at measurement of ldl (years) (HARMONIZED),LDL CHOLESTEROL 6 YEARS,131933,0.6884684,,"ALIGNMENT: To align the new variable ""age at measurement of ldl (years)"" with the selected existing variable ""LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 3,"" you would need to ensure that the age at the time of measurement matches the year 3 time point. This means that the age should correspond to the specific time point when the LDL cholesterol level was measured in the dataset. By harmonizing the age variable with the LDL cholesterol measurement at year 3, you can maintain consistency and compatibility within the data repository.",,
age_at_ldl,age at measurement of ldl (years) (HARMONIZED),LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 3,131973,0.53913486,,,,
age_at_ldl,age at measurement of ldl (years) (HARMONIZED),LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 1,131971,0.48751327,,,,
age_at_lymphocyte_ncnc_bld,age at measurement of lymphocyte_ncnc_bld (years) (HARMONIZED),AGE AT BLOOD OR LYMPH CANCER,16534,0.035144847,,"ALIGNMENT: To align the new variable ""age at measurement of lymphocyte_ncnc_bld (years)"" with the existing variable ""AGE AT BLOOD OR LYMPH CANCER,"" you should ensure that the measurement of lymphocyte count in blood is associated with the diagnosis of blood or lymph cancer. This alignment will help in harmonizing the new variable with the existing variable by linking the age at which the lymphocyte count was measured with the diagnosis of blood or lymph cancer.",,
age_at_lymphocyte_ncnc_bld,age at measurement of lymphocyte_ncnc_bld (years) (HARMONIZED),DATE OF LYMPHOCYTE COUNT (DATE TO DAYS),61268,0.031084951,,,,
age_at_lymphocyte_ncnc_bld,age at measurement of lymphocyte_ncnc_bld (years) (HARMONIZED),DAYS FROM RANDOMIZATION TO DATE OF LYMPHOCYTE COUNT,64945,0.01302049,,,,
age_at_mch_entmass_rbc,age at measurement of mch_entmass_rbc (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.19042274,,"ALIGNMENT: To align the new variable ""age at measurement of mch_entmass_rbc (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age recorded for the measurement of mean corpuscular hemoglobin concentration in red blood cells is consistent with the age of the individual at the time of measurement. This alignment will help maintain the demographic consistency in the data repository.",,
age_at_mch_entmass_rbc,age at measurement of mch_entmass_rbc (years) (HARMONIZED),UNITS - MCHC,243063,0.1261379,,,,
age_at_mch_entmass_rbc,age at measurement of mch_entmass_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.086632065,,,,
age_at_mchc_mcnc_rbc,age at measurement of mchc_mcnc_rbc (years) (HARMONIZED),UNITS - MCHC,243063,0.22236222,,"ALIGNMENT: To align the new variable ""age at measurement of mchc_mcnc_rbc (years)"" with the existing variable MCHC, you should ensure that the measurement of MCHC is taken at the same age as indicated in the new variable. This will help in harmonizing the data and ensuring consistency in the repository.",,
age_at_mchc_mcnc_rbc,age at measurement of mchc_mcnc_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.15752527,,,,
age_at_mchc_mcnc_rbc,age at measurement of mchc_mcnc_rbc (years) (HARMONIZED),MCHC,142506,0.12527926,,,,
age_at_mcv_entvol_rbc,age at measurement of mcv_entvol_rbc (years) (HARMONIZED),MCV,142587,0.16559312,,"ALIGNMENT: To align the new variable ""age at measurement of mcv_entvol_rbc (years)"" with the existing variable MCV, ensure that the age at which the measurement was taken is accurately recorded and associated with the mean cell volume values. This will allow for proper analysis and comparison of MCV values across different age groups.",,
age_at_mcv_entvol_rbc,age at measurement of mcv_entvol_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.104660206,,,,
age_at_mcv_entvol_rbc,age at measurement of mcv_entvol_rbc (years) (HARMONIZED),MEAN CELL VOLUME (MCV),143075,0.07793769,,,,
age_at_monocyte_ncnc_bld,age at measurement of monocyte_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.23144047,,"ALIGNMENT: To align the new variable ""age at measurement of monocyte_ncnc_bld (years) (HARMONIZED)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age provided in the new variable is in years and corresponds to the age at which the measurement of monocyte_ncnc_bld was taken. This alignment will help maintain consistency and facilitate data analysis across different variables in the repository.",,
age_at_monocyte_ncnc_bld,age at measurement of monocyte_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.1328517,,,,
age_at_monocyte_ncnc_bld,age at measurement of monocyte_ncnc_bld (years) (HARMONIZED),CD34P_AC133P_B1 PERIPHERAL BLOOD MEASURE AT BASELINE,44029,0.041230027,,,,
age_at_neutrophil_ncnc_bld,age at measurement of neutrophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.13788034,,"ALIGNMENT: To align the new variable ""age at measurement of neutrophil_ncnc_bld (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age provided in the new variable corresponds to the age at which the neutrophil count measurement was taken. This alignment will help maintain consistency in the dataset and allow for proper analysis of age-related factors in relation to neutrophil counts.",,
age_at_neutrophil_ncnc_bld,age at measurement of neutrophil_ncnc_bld (years) (HARMONIZED),ABSOLUTE NEUTROPHIL COUNT (ANC),12042,0.0921962,,,,
age_at_neutrophil_ncnc_bld,age at measurement of neutrophil_ncnc_bld (years) (HARMONIZED),II_3B ABSOLUTE NEUTROPHIL COUNT (ANC),121311,0.08093671,,,,
age_at_platelet_ncnc_bld,age at measurement of platelet_ncnc_bld (years) (HARMONIZED),DAYS TO DATE OF PLATELETS MEASUREMENT,66303,0.29421496,,"ALIGNMENT: To align the new variable ""age at measurement of platelet_ncnc_bld (years)"" with the existing variable ""AGE AT MEASUREMENT,"" ensure that the measurement of platelet_ncnc_bld is taken at the same time point as the age measurement. This will allow for direct comparison and harmonization of the two variables based on the individual's age at the time of measurement.",,
age_at_platelet_ncnc_bld,age at measurement of platelet_ncnc_bld (years) (HARMONIZED),AGE (YRS) RECVD A TRANSFUSION OF PLATELE,16419,0.28866935,,,,
age_at_platelet_ncnc_bld,age at measurement of platelet_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.17981844,,,,
age_at_pmv_entvol_bld,age at measurement of pmv_entvol_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.19961987,,"ALIGNMENT: To align the new variable ""age at measurement of pmv_entvol_bld"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age is recorded in years at the time of measurement. If the new variable is already in years, no further alignment is necessary. If the new variable is in a different unit, convert it to years for consistency with the existing variable.",,
age_at_pmv_entvol_bld,age at measurement of pmv_entvol_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.12940273,,,,
age_at_pmv_entvol_bld,age at measurement of pmv_entvol_bld (years) (HARMONIZED),YEAR OF MEASUREMENT,258930,0.034880888,,,,
age_at_rbc_ncnc_bld,age at measurement of rbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.23335676,,"ALIGNMENT: To align the new variable ""age at measurement of rbc_ncnc_bld (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age captured in the new variable is consistent with the age recorded at the time of measurement in years. This alignment will help maintain uniformity and compatibility with existing data in the repository.",,
age_at_rbc_ncnc_bld,age at measurement of rbc_ncnc_bld (years) (HARMONIZED),DATE OF RBC (DATE TO DAYS),61524,0.10539455,,,,
age_at_rbc_ncnc_bld,age at measurement of rbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.10248422,,,,
age_at_rdw_ratio_rbc,age at measurement of rdw_ratio_rbc (years) (HARMONIZED),RDW (%),195309,0.20625381,,"ALIGNMENT: To align the new variable ""age at measurement of rdw_ratio_rbc (years)"" with the selected existing variable ""RDW (%)"", you can consider calculating the age at measurement in years and then analyzing the red cell distribution width ratio in relation to the age of the individual. This alignment will help in harmonizing the new variable with the existing variable and ensure consistency in the data repository.",,
age_at_rdw_ratio_rbc,age at measurement of rdw_ratio_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.09170696,,,,
age_at_rdw_ratio_rbc,age at measurement of rdw_ratio_rbc (years) (HARMONIZED),RED CELL DISTRIBUTION WIDTH (RDW) (%),199505,0.05997644,,,,
age_at_total_cholesterol,age at measurement of total_cholesterol (years) (HARMONIZED),TOTAL CHOLESTEROL 6 YEARS,236863,0.5590192,,"ALIGNMENT: To align the new variable ""age at measurement of total_cholesterol (years)"" with the selected existing variable ""TOTAL CHOLESTEROL (MG/DL) AT YEAR 1"", you should ensure that the age at measurement corresponds to the time point of year 1 when the total cholesterol level was measured in mg/dL. This alignment will help maintain consistency and compatibility with the existing data in the repository.",,
age_at_total_cholesterol,age at measurement of total_cholesterol (years) (HARMONIZED),TOTAL CHOLESTEROL (MG/DL) AT YEAR 1,236845,0.5074343,,,,
age_at_total_cholesterol,age at measurement of total_cholesterol (years) (HARMONIZED),TOTAL CHOLESTEROL 2 YEARS,236861,0.40309682,,,,
age_at_triglycerides,age at measurement of triglycerides (HARMONIZED),AGE AT LIPID DETERMINATION,16674,0.2007143,,"ALIGNMENT: To align the new variable ""age at measurement of triglycerides (HARMONIZED)"" with the existing variable ""AGE AT MEASUREMENT,"" ensure that the age at which triglyceride measurements were taken is consistent with the age at which other measurements were taken in the dataset. This will help in harmonizing the new variable with the existing age variable for accurate analysis and interpretation.",,
age_at_triglycerides,age at measurement of triglycerides (HARMONIZED),AGE AT MEASUREMENT,16680,0.13986565,,,,
age_at_triglycerides,age at measurement of triglycerides (HARMONIZED),FASTING TRIGLYCERIDES (MG/DL),92884,0.013480103,,,,
age_at_wbc_ncnc_bld,age at measurement of wbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.20577459,,"ALIGNMENT: To align the new variable ""age at measurement of WBC_ncnc_bld (years)"" with the selected existing variable ""AGE AT MEASUREMENT,"" ensure that the age information provided in the new variable is consistent with the age calculation methodology used in the existing variable. This may involve converting the age measurement in years to match the format and calculation method of the existing variable. Additionally, consider any adjustments or transformations needed to harmonize the new variable with the existing variable for accurate data integration.",,
age_at_wbc_ncnc_bld,age at measurement of wbc_ncnc_bld (years) (HARMONIZED),DATE OF WBC (DATE TO DAYS),61848,0.10932483,,,,
age_at_wbc_ncnc_bld,age at measurement of wbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.0946777,,,,
basophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of basophils in the blood (bld). (thousands / microliter) (HARMONIZED)","WHITE BLOOD COUNT, THOUSANDS PER MICROLITER",256039,0.5681163,,"ALIGNMENT: To align the new variable with ""WHITE BLOOD COUNT, THOUSANDS PER MICROLITER,"" ensure that the count by volume of basophils in the blood is also reported in thousands per microliter. This will harmonize the new variable with the existing variable in the repository.",,
basophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of basophils in the blood (bld). (thousands / microliter) (HARMONIZED)",WHITE BLOOD CELL COUNT (X10/L),256004,0.18300885,,,,
basophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of basophils in the blood (bld). (thousands / microliter) (HARMONIZED)",WHITE BLOOD CELL COUNT,255992,0.14928317,,,,
eosinophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of eosinophils in the blood (bld). (thousands / microliter) (HARMONIZED)",EOSINOPHIL COUNT (X10^3/UL),82891,0.59819484,,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement unit is consistent (cells/microliter) and that the count is an absolute count of eosinophils in the blood. Additionally, consider including a range of 0-9999/UL to capture the possible values accurately. This alignment will help maintain consistency and compatibility with existing data in the repository.",,
eosinophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of eosinophils in the blood (bld). (thousands / microliter) (HARMONIZED)",CBC WITH DIFFERENTIAL CELL COUNT: EOSINOPHILS (ABSOLUTE COUNT) (0-9999/UL),43565,0.5467079,,,,
eosinophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of eosinophils in the blood (bld). (thousands / microliter) (HARMONIZED)","TOTAL EOSINOPHIL COUNT, CELLS/MICROLITER",237142,0.26038945,,,,
hdl,Hdl cholesterol (mg/dl) (HARMONIZED),HDL-CHOLESTEROL (MG/DL),108809,0.65301627,,"ALIGNMENT: To align the new variable ""Hdl cholesterol (mg/dl) (HARMONIZED)"" with the selected existing variable ""HDL-CHOLESTEROL (MG/DL)"", ensure that the measurement units are consistent (milligrams per deciliter) and that the definition of the variable matches the concept of HDL cholesterol. Additionally, consider any specific guidelines or protocols for measuring and reporting HDL cholesterol levels to maintain harmonization with the existing variable.",,
hdl,Hdl cholesterol (mg/dl) (HARMONIZED),HDL-C CHOLESTEROL (MG/DL),108807,0.6237207,,,,
hdl,Hdl cholesterol (mg/dl) (HARMONIZED),TOTAL HDL CHOLESTEROL (MG/DL),237299,0.5718264,,,,
hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD),110470,0.9404625,,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement method and units used for calculating the percentage of red blood cells in whole blood are consistent. Additionally, consider any specific guidelines or protocols followed for hematocrit measurements in the repository to maintain harmonization.",,
hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",BLOOD ANALYSIS: HEMATOCRIT,34250,0.9206471,,,,
hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (HCT) (%),110482,0.90397453,,,,
hemoglobin_mcnc_bld,"Measurement of mass per volume, or mass concentration (mcnc), of hemoglobin in the blood (bld). (g / dL = grams per deciliter) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.9418684,,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement of mass per volume of hemoglobin in the blood is calculated in grams per deciliter (g/dL) and that it specifically pertains to the average concentration in packed red blood cells. This will harmonize the new variable with the existing variable ""MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)"" in the data repository.",,
hemoglobin_mcnc_bld,"Measurement of mass per volume, or mass concentration (mcnc), of hemoglobin in the blood (bld). (g / dL = grams per deciliter) (HARMONIZED)",MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC) (G/DL),143098,0.81626,,,,
hemoglobin_mcnc_bld,"Measurement of mass per volume, or mass concentration (mcnc), of hemoglobin in the blood (bld). (g / dL = grams per deciliter) (HARMONIZED)",MEAN CELLULAR HEMOGLOBIN CONCENTRATION(GM/DL),143077,0.755637,,,,
ldl,Ldl cholesterol (mg/dl) (HARMONIZED),LDL CHOLESTEROL CALCULATED (MG/DL),131935,0.91165274,,"ALIGNMENT: To align the new variable ""Ldl cholesterol (mg/dl) (HARMONIZED)"" with the selected existing variable ""LDL CHOLESTEROL (MG/DL),"" ensure that the measurement units are consistent (mg/dl) and that the method of measurement aligns with the direct measurement of LDL cholesterol. Additionally, consider any specific guidelines or protocols related to the measurement of LDL cholesterol in the dataset to ensure accurate harmonization.",,
ldl,Ldl cholesterol (mg/dl) (HARMONIZED),LDL CHOLESTEROL (MG/DL),131927,0.9092645,,,,
ldl,Ldl cholesterol (mg/dl) (HARMONIZED),LDL-CHOLESTEROL (MG/DL),131974,0.8929365,,,,
lymphocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of lymphocytes in the blood (bld). (thousands / microliter) (HARMONIZED)",LYMPHOCYTE COUNT (X10^3/UL),140055,0.12474515,,"ALIGNMENT: To align the new variable with the selected existing variable ""LYMPHOCYTE COUNT,"" ensure that the count of lymphocytes in the blood is measured in thousands per microliter. This will harmonize the new variable with the existing variable and maintain consistency in the data repository.",,
lymphocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of lymphocytes in the blood (bld). (thousands / microliter) (HARMONIZED)",LYMPHOCYTE COUNT,140052,0.10266401,,,,
lymphocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of lymphocytes in the blood (bld). (thousands / microliter) (HARMONIZED)",LYMPHOCYTE COUNT (X10E9),140053,0.09186978,,,,
mch_entmass_rbc,"Measurement of the average mass (entmass) of hemoglobin per red blood cell(rbc), known as mean corpuscular hemoglobin (MCH). (pg = picogram) (HARMONIZED)",MEAN CORPUSCULAR HEMOGLOBIN (MCH) (PG),143090,0.9863632,,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement units are consistent (picograms). Additionally, consider the methodology and instruments used for measuring mean corpuscular hemoglobin to ensure harmonization with the existing variable. Regularly update and cross-reference the data to maintain accuracy and consistency.",,
mch_entmass_rbc,"Measurement of the average mass (entmass) of hemoglobin per red blood cell(rbc), known as mean corpuscular hemoglobin (MCH). (pg = picogram) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN, MCH (PG)",143101,0.98538435,,,,
mch_entmass_rbc,"Measurement of the average mass (entmass) of hemoglobin per red blood cell(rbc), known as mean corpuscular hemoglobin (MCH). (pg = picogram) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.9481545,,,,
mchc_mcnc_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",MCHC - MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION - NUMERIC VALUE G/DL,142510,0.98926485,,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement of the mass concentration of hemoglobin in packed red blood cells is calculated and reported in grams per deciliter (g/dL). This will harmonize the new variable with the existing variable MCHC in the data repository.",,
mchc_mcnc_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",CHCM (G/DL) - MEAN OF THE RBC HGB CONCENTRATION,45928,0.9854964,,,,
mchc_mcnc_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.98141783,,,,
mcv_entvol_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",MCHC - MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION - NUMERIC VALUE G/DL,142510,0.98926485,,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement of the mass concentration of hemoglobin in packed red blood cells is reported in grams per deciliter. This will harmonize the new variable with the existing variable MCHC in the data repository.",,
mcv_entvol_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",CHCM (G/DL) - MEAN OF THE RBC HGB CONCENTRATION,45928,0.9854964,,,,
mcv_entvol_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.98141783,,,,
monocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of monocytes in the blood (bld). (HARMONIZED)",MONOCYTE COUNT,152746,0.4499968,,"ALIGNMENT: To align the new variable with the selected existing variable, you can calculate the percentage of monocytes in the total white blood cell count. This can be done by dividing the count of monocytes by the total white blood cell count and multiplying by 100 to get the percentage. This will harmonize the new variable with the existing variable MONOCYTE PERCENTAGE.",,
monocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of monocytes in the blood (bld). (HARMONIZED)",WHITE BLOOD CELL COUNT (MM3),256002,0.22422527,,,,
monocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of monocytes in the blood (bld). (HARMONIZED)",WHITE BLOOD CELL COUNT (CELLS/MM3),255999,0.13217814,,,,
neutrophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld). (HARMONIZED)",NEUTROPHIL COUNT (ANC),157930,0.33709443,,"ALIGNMENT: To align the new variable ""Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld)"" with the selected existing variable ""ABSOLUTE NEUTROPHIL COUNT (ANC)"", you should ensure that the measurement units and methods used to calculate the absolute neutrophil count are consistent with the new variable. This may involve converting the count by volume or number concentration to an absolute count and ensuring that the measurement is standardized across the dataset. Additionally, it would be beneficial to document any specific assay or method used to measure the absolute neutrophil count for future reference and harmonization efforts.",,
neutrophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld). (HARMONIZED)",ABSOLUTE NEUTROPHIL COUNT (ANC),12042,0.33513322,,,,
neutrophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld). (HARMONIZED)",II_3B ABSOLUTE NEUTROPHIL COUNT (ANC),121311,0.25608712,,,,
platelet_ncnc_bld,"Count by volume, or number concentration (ncnc), of platelets in the blood (bld). (thousands / microliter) (HARMONIZED)","PLATELET COUNT, THOUSANDS PER MICROLITER",183333,0.95506835,,"ALIGNMENT: To align the new variable with the selected existing variable ""PLATELET COUNT, THOUSANDS PER MICROLITER,"" ensure that the count of platelets in the blood is measured in thousands per microliter. This will harmonize the new variable with the existing variable in the repository.",,
platelet_ncnc_bld,"Count by volume, or number concentration (ncnc), of platelets in the blood (bld). (thousands / microliter) (HARMONIZED)",PLATELET COUNT (1000/MM3),183280,0.9361684,,,,
platelet_ncnc_bld,"Count by volume, or number concentration (ncnc), of platelets in the blood (bld). (thousands / microliter) (HARMONIZED)",PLATELET COUNT (10^9/L),183283,0.8690492,,,,
pmv_entvol_bld,"Measurement of the mean volume (entvol) of platelets in the blood (bld), known as mean platelet volume (MPV or PMV). (fL = femtoliter) (HARMONIZED)",MPV - MEAN PLATELET VOLUME - NUMERIC VALUE FL,154727,0.9881766,,"ALIGNMENT: To align the new variable with the selected existing variable ""MPV - MEAN PLATELET VOLUME - NUMERIC VALUE FL"", ensure that the measurement of the mean volume of platelets in the blood is recorded in femtoliters (fL) for consistency with the existing variable. This will help maintain uniformity in the data repository and facilitate data analysis and interpretation.",,
pmv_entvol_bld,"Measurement of the mean volume (entvol) of platelets in the blood (bld), known as mean platelet volume (MPV or PMV). (fL = femtoliter) (HARMONIZED)","MEAN PLATELET VOLUME, MPV (ΜM3)",144603,0.98072886,,,,
pmv_entvol_bld,"Measurement of the mean volume (entvol) of platelets in the blood (bld), known as mean platelet volume (MPV or PMV). (fL = femtoliter) (HARMONIZED)",MEAN PLATELET VOLUME (FL),144601,0.9757161,,,,
rbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of red blood cells in the blood (bld). (millions / microliter) (HARMONIZED)","RED BLOOD COUNT, MILLIONS PER MICROLITER",199494,0.9666632,,"ALIGNMENT: To align the new variable with the selected existing variable ""RED BLOOD CELL COUNT,"" ensure that the units are consistent (millions per microliter) and that the measurement represents the count of red blood cells in a specific volume of blood. Additionally, consider any specific protocols or methodologies used to measure red blood cell count to ensure harmonization with the existing variable.",,
rbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of red blood cells in the blood (bld). (millions / microliter) (HARMONIZED)",RED BLOOD CELL COUNT,199474,0.8767399,,,,
rbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of red blood cells in the blood (bld). (millions / microliter) (HARMONIZED)",RED BLOOD CELL COUNT (MILLIONS CELLS/UL),199478,0.8715842,,,,
rdw_ratio_rbc,"Measurement of the ratio of variation in width to the mean width of the red blood cell (rbc) volume distribution curve taken at +/- 1 CV, known as red cell distribution width (RDW). (percentage) (HARMONIZED)",RDW - RED CELL DISTRIBUTION WIDTH - NUMERIC VALUE %,195310,0.99351174,,"ALIGNMENT: To align the new variable with the selected existing variable RDW, ensure that the measurement of the ratio of variation in width to the mean width of the red blood cell volume distribution curve is accurately represented as a numeric value percentage. This will harmonize the new variable with the existing variable RDW in the data repository.",,
rdw_ratio_rbc,"Measurement of the ratio of variation in width to the mean width of the red blood cell (rbc) volume distribution curve taken at +/- 1 CV, known as red cell distribution width (RDW). (percentage) (HARMONIZED)",RED CELL DISTRIBUTION WIDTH (RDW) (%),199505,0.99010193,,,,
rdw_ratio_rbc,"Measurement of the ratio of variation in width to the mean width of the red blood cell (rbc) volume distribution curve taken at +/- 1 CV, known as red cell distribution width (RDW). (percentage) (HARMONIZED)","RED CELL DISTRIBUTION WIDTH, RDW (%)",199507,0.9896718,,,,
total_cholesterol,Total cholesterol (mg/dl) (HARMONIZED),TOTAL CHOLESTEROL (MG/DL),236841,0.9360516,,"ALIGNMENT: To align your new variable ""Total cholesterol (mg/dl) (HARMONIZED)"" with the selected existing variable ""TOTAL CHOLESTEROL (MG/DL)"", ensure that the measurement unit is consistent (mg/dL) and that the data collection method and timing align with how total cholesterol levels are typically measured in the dataset. Additionally, consider any potential differences in data collection protocols or sources that may impact the harmonization process.",,
total_cholesterol,Total cholesterol (mg/dl) (HARMONIZED),TOTAL CHOLESTEROL (MG-DL),236839,0.9136765,,,,
total_cholesterol,Total cholesterol (mg/dl) (HARMONIZED),TOTAL HDL CHOLESTEROL (MG/DL),237299,0.84221536,,,,
triglycerides,Triglycerides (mg/dl) (HARMONIZED),TOTAL TRIGLYCERIDES (MG/DL),238621,0.5616356,,"ALIGNMENT: To align the new variable ""Triglycerides (mg/dl) (HARMONIZED)"" with the selected existing variable ""TOTAL TRIGLYCERIDES (MG/DL)"", ensure that the measurement units are consistent (mg/dl) and that the calculation method for determining triglyceride levels remains the same. Additionally, consider any specific guidelines or protocols related to measuring and reporting triglyceride levels in the dataset to ensure harmonization with the existing variable.",,
triglycerides,Triglycerides (mg/dl) (HARMONIZED),TOTAL TRIGLYCERIDES (MG-DL),238620,0.5201764,,,,
triglycerides,Triglycerides (mg/dl) (HARMONIZED),NON-FASTING TRIGLYCERIDES (MG/DL),160094,0.3599264,,,,
unit_basophil_ncnc_bld,"harmonization unit for basophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HYPERSEGMENTED NEUTROPHILS (LABA63),117756,0.97813547,,"ALIGNMENT: To align the new variable ""harmonization unit for basophil_ncnc_bld"" with the existing variable ""OBSERVATION UNIT,"" you should define a standardized unit of observation for basophil counts in blood samples. This will ensure consistency and comparability across different studies and datasets. Additionally, consider documenting any specific protocols or guidelines for measuring and reporting basophil counts to facilitate harmonization with existing data.",,
unit_basophil_ncnc_bld,"harmonization unit for basophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.97399324,,,,
unit_basophil_ncnc_bld,"harmonization unit for basophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PROCALCITONIN UNIT,187463,0.9642542,,,,
unit_eosinophil_ncnc_bld,"harmonization unit for eosinophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.95195264,,"ALIGNMENT: To align the new variable ""harmonization unit for eosinophil_ncnc_bld"" with the existing variable ""OBSERVATION UNIT,"" you should consider defining the specific group of subjects or samples that will be included in this harmonization unit. This could involve specifying criteria such as age range, disease status, treatment group, or any other relevant characteristics that define the group. Additionally, ensure that the data collected for this variable is consistent with the unit of observation specified in the ""OBSERVATION UNIT"" variable to maintain data integrity and facilitate analysis.",,
unit_eosinophil_ncnc_bld,"harmonization unit for eosinophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HYPERSEGMENTED NEUTROPHILS (LABA63),117756,0.9452985,,,,
unit_eosinophil_ncnc_bld,"harmonization unit for eosinophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PROCALCITONIN UNIT,187463,0.9417614,,,,
unit_hdl,"harmonization unit for hdl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",C_HDL,57197,0.99720997,,"ALIGNMENT: To align the new variable ""harmonization unit for HDL"" with the existing variable C_HDL, you should ensure that the harmonization unit is based on the concentration of HDL in the blood. This means that the new variable should also measure the HDL levels in a similar manner as C_HDL, using the same units of measurement and methodology. Additionally, it is important to consider the context in which the harmonization unit is defined and ensure that it aligns with the scientific principles underlying the measurement of HDL. By harmonizing the new variable with C_HDL, you can ensure consistency and comparability with existing data in the repository.",,
unit_hdl,"harmonization unit for hdl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",LN(HDL),136423,0.99703056,,,,
unit_hdl,"harmonization unit for hdl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEMOGLOBIN UNIT,110764,0.99554896,,,,
unit_hematocrit_vfr_bld,"harmonization unit for hematocrit_vfr_bld. (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEMATOCRIT UNIT,110516,0.99716616,,"ALIGNMENT: To align the new variable ""harmonization unit for hematocrit_vfr_bld"" with the existing variable ""HEMATOCRIT UNIT,"" ensure that the unit of measurement for hematocrit levels in the blood is consistent and standardized across the data repository. This will help in harmonizing the new variable with the existing variable and ensure data integrity and comparability.",,
unit_hematocrit_vfr_bld,"harmonization unit for hematocrit_vfr_bld. (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - HCT,243059,0.9867261,,,,
unit_hematocrit_vfr_bld,"harmonization unit for hematocrit_vfr_bld. (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HAEMOGLOBIN UNIT,105983,0.98255754,,,,
unit_hemoglobin_mcnc_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD),110470,0.9404625,,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the measurement method and units for calculating the percentage of red blood cells in whole blood are consistent with how the existing variable is defined. Additionally, consider any specific guidelines or protocols related to hematocrit measurements in the repository to ensure harmonization.",,
unit_hemoglobin_mcnc_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",BLOOD ANALYSIS: HEMATOCRIT,34250,0.9206471,,,,
unit_hemoglobin_mcnc_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (HCT) (%),110482,0.90397453,,,,
unit_ldl,"harmonization unit for ldl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",LDH UNIT,131898,0.9847524,,"ALIGNMENT: To align the new variable ""harmonization unit for ldl"" with the existing variable LDH UNIT, you should ensure that the units for LDL (low-density lipoprotein) levels are consistent with the units used for LDH in the data repository. If LDH is measured in U/L or %, then LDL should also be measured in the same units for harmonization purposes. Additionally, consider any conversion factors that may be necessary to standardize the units across variables.",,
unit_ldl,"harmonization unit for ldl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","UNITS FOR LDH2:A=U/L,B=%)",243078,0.97850823,,,,
unit_ldl,"harmonization unit for ldl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.97046465,,,,
unit_lymphocyte_ncnc_bld,"harmonization unit for lymphocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.99424744,,"ALIGNMENT: To align the new variable ""harmonization unit for lymphocyte_ncnc_bld"" with the existing variable ""LYMPHOCYTE (10^3/UL) [7/15/95]"", ensure that the measurement unit for lymphocyte count is consistent (thousands per microliter) and that the date format for recording is followed (MM/DD/YY). Additionally, consider the context of the variable in relation to blood samples and immune system function. ",,
unit_lymphocyte_ncnc_bld,"harmonization unit for lymphocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",LYMPHOCYTE (10^3/UL) [7/15/95],140050,0.98742366,,,,
unit_lymphocyte_ncnc_bld,"harmonization unit for lymphocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",# HLA MATCHED UNITS,348,0.98191,,,,
unit_mch_entmass_rbc,"harmonization unit for mch_entmass_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCHC,243063,0.9963783,,"ALIGNMENT: To align the new variable ""harmonization unit for mch_entmass_rbc"" with the existing variable ""UNITS - MCH"", you should consider the hemoglobin content in individual red blood cells. Ensure that the harmonization unit for MCH_entmass_rbc is consistent with the measurement and units used for mean corpuscular hemoglobin. This will help in harmonizing the new variable with the existing variable and maintaining consistency in the data repository.",,
unit_mch_entmass_rbc,"harmonization unit for mch_entmass_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.9961755,,,,
unit_mch_entmass_rbc,"harmonization unit for mch_entmass_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCH,243062,0.99586606,,,,
unit_mchc_mcnc_rbc,"harmonization unit for mchc_mcnc_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCHC,243063,0.9980277,,"ALIGNMENT: To align the new variable ""harmonization unit for mchc_mcnc_rbc"" with the existing variable ""UNITS - MCHC,"" ensure that the units for MCHC and the harmonization unit for mchc_mcnc_rbc are consistent. This may involve converting units if necessary to ensure that the data can be harmonized effectively. Additionally, consider any specific guidelines or standards for reporting MCHC values within the dataset to ensure alignment with the existing variable.",,
unit_mchc_mcnc_rbc,"harmonization unit for mchc_mcnc_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCH,243062,0.99703056,,,,
unit_mchc_mcnc_rbc,"harmonization unit for mchc_mcnc_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.99648935,,,,
unit_mcv_entvol_rbc,"harmonization unit for mcv_entvol_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCHC,243063,0.9972531,,"ALIGNMENT: To align the new variable ""harmonization unit for mcv_entvol_rbc"" with the selected existing variable ""UNITS - MCHC"", ensure that the units used for measuring the mean corpuscular volume (MCV) and red blood cell (RBC) volume are consistent with the units used for measuring mean corpuscular hemoglobin concentration (MCHC). This alignment will help in harmonizing the new variable with the existing variable in the data repository.",,
unit_mcv_entvol_rbc,"harmonization unit for mcv_entvol_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.99708784,,,,
unit_mcv_entvol_rbc,"harmonization unit for mcv_entvol_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.9957684,,,,
unit_monocyte_ncnc_bld,"harmonization unit for monocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.9953544,,"ALIGNMENT: To align the new variable ""harmonization unit for monocyte_ncnc_bld"" with the existing variable ""WBC UNIT"", you can consider using the same unit of measurement for white blood cell count as a reference point for harmonization. This could involve ensuring that the data for both variables are collected and reported in the same units to facilitate comparison and analysis. Additionally, you may want to explore any potential relationships or correlations between white blood cell counts and the specific phenotype being measured in the new variable to further justify the alignment.",,
unit_monocyte_ncnc_bld,"harmonization unit for monocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.98131067,,,,
unit_monocyte_ncnc_bld,"harmonization unit for monocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",# HLA MATCHED UNITS,348,0.9801293,,,,
unit_neutrophil_ncnc_bld,"harmonization unit for neutrophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.9947392,,"ALIGNMENT: To align the new variable ""harmonization unit for neutrophil_ncnc_bld"" with the existing variable ""WBC UNIT,"" you should ensure that the unit of measurement for neutrophil count is consistent with the unit used for white blood cell count. This will help in harmonizing the new variable with the existing data in the repository.",,
unit_neutrophil_ncnc_bld,"harmonization unit for neutrophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - WBC,243072,0.99411184,,,,
unit_neutrophil_ncnc_bld,"harmonization unit for neutrophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HYPERSEGMENTED NEUTROPHILS (LABA63),117756,0.97150993,,,,
unit_platelet_ncnc_bld,"harmonization unit for platelet_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PLATELETS UNIT,183488,0.9962492,,"ALIGNMENT: To align the new variable ""harmonization unit for platelet_ncnc_bld"" with the existing variable ""PLATELETS UNIT,"" you should ensure that the unit of measurement for platelet count in the harmonization unit is consistent with the unit used in the existing variable. Additionally, consider any conversion factors or adjustments needed to make the data comparable across different studies or datasets. It may also be helpful to document any specific guidelines or protocols used for measuring platelet count in the harmonization unit to ensure consistency with the existing variable.",,
unit_platelet_ncnc_bld,"harmonization unit for platelet_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PLATELETS UNITS,183489,0.99556625,,,,
unit_platelet_ncnc_bld,"harmonization unit for platelet_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PATIENT'S PLATELET PHENOTYPE,178508,0.99408895,,,,
unit_pmv_entvol_bld,"harmonization unit for pmv_entvol_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MPV,243066,0.99619037,,"ALIGNMENT: To align the new variable ""harmonization unit for pmv_entvol_bld"" with the existing variable ""UNITS,"" you should ensure that the units used for the measurement of ""pmv_entvol_bld"" are consistent with the units used in the ""UNITS"" variable. This will help ensure that the data is standardized and can be easily compared and analyzed across different studies or datasets.",,
unit_pmv_entvol_bld,"harmonization unit for pmv_entvol_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.97706646,,,,
unit_pmv_entvol_bld,"harmonization unit for pmv_entvol_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.97666925,,,,
unit_rbc_ncnc_bld,"harmonization unit for rbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.99815416,,"ALIGNMENT: To align the new variable ""harmonization unit for rbc_ncnc_bld"" with the existing variable ""UNITS - RBC,"" you should ensure that the harmonization unit for RBC nucleated blood aligns with the units used to measure or count RBCs in the dataset. This could involve standardizing the measurement units or ensuring that the harmonization unit is compatible with the existing units for RBCs in the repository. Additionally, consider any conversion factors or adjustments needed to harmonize the new variable with the existing ""UNITS - RBC"" variable.",,
unit_rbc_ncnc_bld,"harmonization unit for rbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",B4. ABO GROUP OF RBC UNIT,30085,0.9963783,,,,
unit_rbc_ncnc_bld,"harmonization unit for rbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",NUCLEATED RBCS,161411,0.9927672,,,,
unit_rdw_ratio_rbc,"harmonization unit for rdw_ratio_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RDW,243069,0.99592984,,"ALIGNMENT: To align the new variable ""harmonization unit for rdw_ratio_rbc"" with the existing variable ""HEMATOLOGY RBC SI UNITS,"" you should ensure that the units used for the RDW to RBC ratio are consistent with the standardized international units used in hematology for RBC measurements. This will help ensure that the new variable can be harmonized effectively with existing data in the repository.",,
unit_rdw_ratio_rbc,"harmonization unit for rdw_ratio_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.98942953,,,,
unit_rdw_ratio_rbc,"harmonization unit for rdw_ratio_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEMATOLOGY RBC SI UNITS,110561,0.9705206,,,,
unit_total_cholesterol,"harmonization unit for total_cholesterol (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.9938549,,"ALIGNMENT: To align the new variable ""harmonization unit for total_cholesterol"" with the selected existing variable ""TOTAL CHOLESTEROL,"" you should ensure that the harmonization unit is linked to the actual total cholesterol values recorded in the dataset. This can involve mapping the harmonization unit to the corresponding total cholesterol values for each subject, ensuring that the phenotypes within the harmonization unit are processed similarly in relation to total cholesterol levels. Additionally, it is important to document any transformations or calculations applied to derive the harmonization unit from the total cholesterol data.",,
unit_total_cholesterol,"harmonization unit for total_cholesterol (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNITS,236880,0.9917484,,,,
unit_total_cholesterol,"harmonization unit for total_cholesterol (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL.,236912,0.99135584,,,,
unit_triglycerides,"harmonization unit for triglycerides (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TRIGLYCERIDES IN SI UNITS,240630,0.9762653,,"ALIGNMENT: To align the new variable ""harmonization unit for triglycerides"" with the existing variable ""TRIGLYCERIDES IN SI UNITS"", ensure that the harmonization unit is measured in the SI units system. This will allow for consistency and compatibility with the existing data in the repository. Additionally, consider standardizing the measurement techniques and protocols used for collecting triglyceride data to further harmonize the new variable with the existing variable.",,
unit_triglycerides,"harmonization unit for triglycerides (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.9683214,,,,
unit_triglycerides,"harmonization unit for triglycerides (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNITS,236880,0.9596866,,,,
unit_wbc_ncnc_bld,"harmonization unit for wbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - WBC,243072,0.9983451,,"ALIGNMENT: To align the new variable ""harmonization unit for wbc_ncnc_bld"" with the existing variable ""WBC,"" ensure that the measurement and reporting of white blood cell count are consistent. This may involve standardizing units, methodologies, and reporting practices to harmonize the data effectively. Additionally, consider any specific guidelines or protocols related to white blood cell count measurements in the dataset.",,
unit_wbc_ncnc_bld,"harmonization unit for wbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.9974689,,,,
unit_wbc_ncnc_bld,"harmonization unit for wbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.98761624,,,,
wbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of white blood cells in the blood (bld). (thousands / microliter) (HARMONIZED)","WHITE BLOOD COUNT, THOUSANDS PER MICROLITER",256039,0.95877,,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the count of white blood cells is measured in thousands per microliter. This will harmonize the new variable with the existing variable in the data repository.",,
wbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of white blood cells in the blood (bld). (thousands / microliter) (HARMONIZED)",WHITE BLOOD CELL COUNT,255992,0.8822251,,,,
wbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of white blood cells in the blood (bld). (thousands / microliter) (HARMONIZED)",TOTAL WHITE BLOOD COUNT (WBC X 1000),239224,0.831143,,,,
age_at_antihypertensive_meds,age at measurement of antihypertensive_meds (years) (HARMONIZED),"HYPERTENSION MEDS, AGE STARTED USE",117820,0.22337706,,"ALIGNMENT: To align the new variable ""age at measurement of antihypertensive_meds"" with the selected existing variable ""HYPERTENSION (AGE)"", you should ensure that the age at which antihypertensive medications were measured corresponds to the age at which hypertension was diagnosed or identified in individuals. This alignment will help in harmonizing the new variable with existing data on hypertension and age, providing a comprehensive view of cardiovascular health in the dataset.",,
age_at_antihypertensive_meds,age at measurement of antihypertensive_meds (years) (HARMONIZED),HYPERTENSION (AGE),117769,0.12189466,,,,
age_at_antihypertensive_meds,age at measurement of antihypertensive_meds (years) (HARMONIZED),AGE HYPERTENSION,17076,0.09434341,,,,
age_at_fasting_lipids,age at measurement of fasting_lipids (years) (HARMONIZED),AGE AT DIAGNOSIS (YRS) - LIPIDS,16569,0.66974485,,"ALIGNMENT: To align the new variable ""age at measurement of fasting_lipids (years)"" with the existing variable ""AGE AT LIPID DETERMINATION,"" ensure that the age recorded for the measurement of fasting lipids corresponds to the age at which lipid levels were determined in the dataset. This alignment will help maintain consistency and relevance in the data repository.",,
age_at_fasting_lipids,age at measurement of fasting_lipids (years) (HARMONIZED),AGE AT LIPID DETERMINATION,16674,0.32584226,,,,
age_at_fasting_lipids,age at measurement of fasting_lipids (years) (HARMONIZED),FASTING: TOTAL CHOLESTEROL,92892,0.078078166,,,,
age_at_lipid_lowering_medication,age at measurement of age_at_lipid1c (years) (HARMONIZED),AGE AT DIAGNOSIS (YRS) - LIPIDS,16569,0.6579781,,"ALIGNMENT: To align the new variable ""age at measurement of age_at_lipid1c (years)"" with the existing variable ""AGE AT LIPID DETERMINATION,"" ensure that the age recorded for the lipid measurement corresponds to the age at which the lipid determination was made. This will help harmonize the new variable with the existing variable in the data repository.",,
age_at_lipid_lowering_medication,age at measurement of age_at_lipid1c (years) (HARMONIZED),AGE AT LIPID DETERMINATION,16674,0.32852945,,,,
age_at_lipid_lowering_medication,age at measurement of age_at_lipid1c (years) (HARMONIZED),TOTAL CHOLESTEROL (MG/DL) AT YEAR 1,236845,0.04401865,,,,
antihypertensive_meds,Indicator for use of antihypertensive medication at the time of blood pressure measurement. (HARMONIZED),HISTORY OF HYPERTENSION INDICATOR,112509,0.761893,,"ALIGNMENT: To align the new variable ""Indicator for use of antihypertensive medication at the time of blood pressure measurement"" with the existing variable ""HISTORY OF HYPERTENSION INDICATOR,"" you can create a new variable that combines information on the patient's history of hypertension with the use of antihypertensive medication at the time of blood pressure measurement. This combined variable can provide a comprehensive view of the patient's hypertension status and medication use.",,
antihypertensive_meds,Indicator for use of antihypertensive medication at the time of blood pressure measurement. (HARMONIZED),"SYSTOLIC BLOOD PRESSURE, READING #1 AT WITHDRAW DATE OF ANTIHYPERTENSIVE MEDICATION",229129,0.38462317,,,,
antihypertensive_meds,Indicator for use of antihypertensive medication at the time of blood pressure measurement. (HARMONIZED),HOUR OF TIME OF BLOOD PRESSURE MEASUREMENT,114107,0.31195062,,,,
fasting_lipids,Indicates whether participant fasted for at least eight hours prior to blood draw to measure lipids phenotypes. (HARMONIZED),DID SUBJECT FAST PRIOR TO LIPID COLLECTION?,70874,0.83223665,,"ALIGNMENT: To align the new variable with the selected existing variable, ensure that the criteria for fasting for at least eight hours prior to blood draw for lipid phenotypes are consistent with the definition provided in the existing variable ""FASTING TIME OF 8 HOURS OR MORE."" This alignment will help maintain consistency and compatibility within the data repository.",,
fasting_lipids,Indicates whether participant fasted for at least eight hours prior to blood draw to measure lipids phenotypes. (HARMONIZED),FASTING TIME OF 8 HOURS OR MORE,92879,0.46377817,,,,
fasting_lipids,Indicates whether participant fasted for at least eight hours prior to blood draw to measure lipids phenotypes. (HARMONIZED),V5 FASTING TIME OF 8 HOURS OR MORE,245083,0.40739235,,,,
hypertension_meds,Take medication for hypertension (HARMONIZED),MEDICATION FOR HIGH BP/HYPERTENSION,146554,0.6078378,,"ALIGNMENT: To align the new variable ""Take medication for hypertension"" with the selected existing variable ""HYPERTENSION MEDICATION,"" ensure that the new variable captures the specific type or class of medication being taken for hypertension. This alignment will help maintain consistency and accuracy in the data repository.",,
hypertension_meds,Take medication for hypertension (HARMONIZED),HYPERTENSION MEDICATION,117816,0.46198756,,,,
hypertension_meds,Take medication for hypertension (HARMONIZED),REGULAR MEDICATION FOR HYPERTENSION,199960,0.36240488,,,,
lipid_lowering_medication,Any lipid-lowering medication (HARMONIZED),ANY LIPID-LOWERING MEDICATION,21559,0.86511016,,"ALIGNMENT: To align the new variable ""Any lipid-lowering medication (HARMONIZED)"" with the existing variable ""LIPID LOWERING MEDS,"" ensure that the definition of the new variable includes all types of medications used to lower lipids, including statins, fibrates, and other relevant drug classes. Additionally, make sure that the coding and categorization of the new variable align with how ""LIPID LOWERING MEDS"" is currently structured in the data repository. This will help maintain consistency and facilitate data analysis across different studies.",,
lipid_lowering_medication,Any lipid-lowering medication (HARMONIZED),LIPID LOWERING MEDS,135787,0.8044059,,,,
lipid_lowering_medication,Any lipid-lowering medication (HARMONIZED),HYPOLIPIDEMICS (LIPID LOWERING MEDS),117956,0.5307078,,,,
unit_antihypertensive_meds,"harmonization unit for antihypertensive_meds (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MEDICATION UNIT,146894,0.9862577,,"ALIGNMENT: To align the new variable ""harmonization unit for antihypertensive_meds"" with the existing variable ""MEDICATION UNIT,"" ensure that the harmonization unit is defined in a consistent and standardized manner. This could involve specifying the unit of measurement for antihypertensive medications, such as milligrams or tablets, to ensure compatibility with the existing variable. Additionally, consider any specific guidelines or conventions used in the repository for defining medication units to facilitate harmonization.",,
unit_antihypertensive_meds,"harmonization unit for antihypertensive_meds (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS OF MEDICATION 7,243090,0.9805806,,,,
unit_antihypertensive_meds,"harmonization unit for antihypertensive_meds (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS OF MEDICATION 2,243085,0.9793541,,,,
unit_fasting_lipids,"harmonization unit for fasting_lipids (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","FASTING LIPIDS, TRIGLYCERIDE",92857,0.9980582,,"ALIGNMENT: To align the new variable with the existing variable FASTING LIPIDS, ensure that the harmonization unit for fasting lipids includes subjects with similar fasting lipid measurements. This may involve setting specific criteria for fasting duration, lipid types measured, and units of measurement to ensure consistency across subjects. Additionally, consider any data processing steps or normalization techniques used for the existing FASTING LIPIDS variable and apply them to the new variable for harmonization.",,
unit_fasting_lipids,"harmonization unit for fasting_lipids (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HDL-1ST COMPLETE LIPIDS,108789,0.9916842,,,,
unit_fasting_lipids,"harmonization unit for fasting_lipids (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.9250947,,,,
unit_lipid_lowering_medication,"harmonization unit for unit_lipid1c (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HDL-1ST COMPLETE LIPIDS,108789,0.99010193,,"ALIGNMENT: To align the new variable ""harmonization unit for unit_lipid1c"" with the existing variable ""HDL-1ST COMPLETE LIPIDS,"" you should ensure that the harmonization unit captures similar information related to lipid levels, specifically focusing on high-density lipoprotein (HDL) cholesterol. This may involve standardizing the measurement units, data collection methods, and reporting formats to ensure consistency with the existing variable. Additionally, consider any specific guidelines or protocols related to lipid profiling in the data repository to harmonize the new variable effectively.",,
unit_lipid_lowering_medication,"harmonization unit for unit_lipid1c (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.9360516,,,,
unit_lipid_lowering_medication,"harmonization unit for unit_lipid1c (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.91196686,,,,